Upregulation and redistribution of integrin α6β4 expression occurs at an early stage in pancreatic adenocarcinoma progression

Zobeida Cruz-Monserrate, Suimin Qiu, B. Mark Evers, Kathleen L. O'Connor

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Pancreatic adenocarcinomas are highly invasive cancers for reasons that are currently unclear. Here we sought to determine if the proinvasive integrin α6β4 may be related to pancreatic adenocarcinoma tumor progression. Expression of integrin α6β4 was analyzed via immunohistochemistry for the β4 subunit in normal pancreas, pancreatic intraepithelial neoplasia (PanIN) lesions, pancreatic adenocarcinomas and chronic pancreatitis. In normal pancreatic ducts, integrin α6β4 was noted only at the cell's basal interface with the basement membrane. In pancreatic adenocarcinomas, 92% (104/113) demonstrated overexpression of integrin α6β4 and altered localization to the cytoplasm and membranous regions. This pattern of expression was observed in all PanIN lesions as early as PanIN-1A, and was evident in lesions that were juxtapositioned to normal epithelium. In contrast, 93% (13/14) of chronic pancreatitis samples resembled the staining pattern of normal pancreas. When cancer was present in areas of chronic pancreatitis, this altered expression of α6β4 integrin identified the cancer. We conclude that integrin α6β4 is expressed only on the basal surface of ductal cells in normal pancreas and chronic pancreatitis. During pancreatic adenocarcinoma progression, the α6β4 integrin is dramatically overexpressed and displays altered localization at the earliest stages of PanIN, thus representing an early event in pancreatic adenocarcinoma progression.

Original languageEnglish (US)
Pages (from-to)656-667
Number of pages12
JournalModern Pathology
Volume20
Issue number6
DOIs
StatePublished - Jun 2007

Fingerprint

Integrins
Adenocarcinoma
Up-Regulation
Chronic Pancreatitis
Neoplasms
Pancreas
Pancreatic Ducts
Basement Membrane
Cytoplasm
Epithelium
Immunohistochemistry
Staining and Labeling

Keywords

  • Chronic pancreatitis
  • Immunohistochemistry
  • Integrins
  • Pancreatic cancer
  • Pancreatic intraepithelial neoplasia (PanINs)
  • Precursor lesion

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Upregulation and redistribution of integrin α6β4 expression occurs at an early stage in pancreatic adenocarcinoma progression. / Cruz-Monserrate, Zobeida; Qiu, Suimin; Evers, B. Mark; O'Connor, Kathleen L.

In: Modern Pathology, Vol. 20, No. 6, 06.2007, p. 656-667.

Research output: Contribution to journalArticle

Cruz-Monserrate, Zobeida ; Qiu, Suimin ; Evers, B. Mark ; O'Connor, Kathleen L. / Upregulation and redistribution of integrin α6β4 expression occurs at an early stage in pancreatic adenocarcinoma progression. In: Modern Pathology. 2007 ; Vol. 20, No. 6. pp. 656-667.
@article{e47ee92b82574ed0884afe84ea221aee,
title = "Upregulation and redistribution of integrin α6β4 expression occurs at an early stage in pancreatic adenocarcinoma progression",
abstract = "Pancreatic adenocarcinomas are highly invasive cancers for reasons that are currently unclear. Here we sought to determine if the proinvasive integrin α6β4 may be related to pancreatic adenocarcinoma tumor progression. Expression of integrin α6β4 was analyzed via immunohistochemistry for the β4 subunit in normal pancreas, pancreatic intraepithelial neoplasia (PanIN) lesions, pancreatic adenocarcinomas and chronic pancreatitis. In normal pancreatic ducts, integrin α6β4 was noted only at the cell's basal interface with the basement membrane. In pancreatic adenocarcinomas, 92{\%} (104/113) demonstrated overexpression of integrin α6β4 and altered localization to the cytoplasm and membranous regions. This pattern of expression was observed in all PanIN lesions as early as PanIN-1A, and was evident in lesions that were juxtapositioned to normal epithelium. In contrast, 93{\%} (13/14) of chronic pancreatitis samples resembled the staining pattern of normal pancreas. When cancer was present in areas of chronic pancreatitis, this altered expression of α6β4 integrin identified the cancer. We conclude that integrin α6β4 is expressed only on the basal surface of ductal cells in normal pancreas and chronic pancreatitis. During pancreatic adenocarcinoma progression, the α6β4 integrin is dramatically overexpressed and displays altered localization at the earliest stages of PanIN, thus representing an early event in pancreatic adenocarcinoma progression.",
keywords = "Chronic pancreatitis, Immunohistochemistry, Integrins, Pancreatic cancer, Pancreatic intraepithelial neoplasia (PanINs), Precursor lesion",
author = "Zobeida Cruz-Monserrate and Suimin Qiu and Evers, {B. Mark} and O'Connor, {Kathleen L.}",
year = "2007",
month = "6",
doi = "10.1038/modpathol.3800782",
language = "English (US)",
volume = "20",
pages = "656--667",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Upregulation and redistribution of integrin α6β4 expression occurs at an early stage in pancreatic adenocarcinoma progression

AU - Cruz-Monserrate, Zobeida

AU - Qiu, Suimin

AU - Evers, B. Mark

AU - O'Connor, Kathleen L.

PY - 2007/6

Y1 - 2007/6

N2 - Pancreatic adenocarcinomas are highly invasive cancers for reasons that are currently unclear. Here we sought to determine if the proinvasive integrin α6β4 may be related to pancreatic adenocarcinoma tumor progression. Expression of integrin α6β4 was analyzed via immunohistochemistry for the β4 subunit in normal pancreas, pancreatic intraepithelial neoplasia (PanIN) lesions, pancreatic adenocarcinomas and chronic pancreatitis. In normal pancreatic ducts, integrin α6β4 was noted only at the cell's basal interface with the basement membrane. In pancreatic adenocarcinomas, 92% (104/113) demonstrated overexpression of integrin α6β4 and altered localization to the cytoplasm and membranous regions. This pattern of expression was observed in all PanIN lesions as early as PanIN-1A, and was evident in lesions that were juxtapositioned to normal epithelium. In contrast, 93% (13/14) of chronic pancreatitis samples resembled the staining pattern of normal pancreas. When cancer was present in areas of chronic pancreatitis, this altered expression of α6β4 integrin identified the cancer. We conclude that integrin α6β4 is expressed only on the basal surface of ductal cells in normal pancreas and chronic pancreatitis. During pancreatic adenocarcinoma progression, the α6β4 integrin is dramatically overexpressed and displays altered localization at the earliest stages of PanIN, thus representing an early event in pancreatic adenocarcinoma progression.

AB - Pancreatic adenocarcinomas are highly invasive cancers for reasons that are currently unclear. Here we sought to determine if the proinvasive integrin α6β4 may be related to pancreatic adenocarcinoma tumor progression. Expression of integrin α6β4 was analyzed via immunohistochemistry for the β4 subunit in normal pancreas, pancreatic intraepithelial neoplasia (PanIN) lesions, pancreatic adenocarcinomas and chronic pancreatitis. In normal pancreatic ducts, integrin α6β4 was noted only at the cell's basal interface with the basement membrane. In pancreatic adenocarcinomas, 92% (104/113) demonstrated overexpression of integrin α6β4 and altered localization to the cytoplasm and membranous regions. This pattern of expression was observed in all PanIN lesions as early as PanIN-1A, and was evident in lesions that were juxtapositioned to normal epithelium. In contrast, 93% (13/14) of chronic pancreatitis samples resembled the staining pattern of normal pancreas. When cancer was present in areas of chronic pancreatitis, this altered expression of α6β4 integrin identified the cancer. We conclude that integrin α6β4 is expressed only on the basal surface of ductal cells in normal pancreas and chronic pancreatitis. During pancreatic adenocarcinoma progression, the α6β4 integrin is dramatically overexpressed and displays altered localization at the earliest stages of PanIN, thus representing an early event in pancreatic adenocarcinoma progression.

KW - Chronic pancreatitis

KW - Immunohistochemistry

KW - Integrins

KW - Pancreatic cancer

KW - Pancreatic intraepithelial neoplasia (PanINs)

KW - Precursor lesion

UR - http://www.scopus.com/inward/record.url?scp=34249097492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249097492&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800782

DO - 10.1038/modpathol.3800782

M3 - Article

C2 - 17415382

AN - SCOPUS:34249097492

VL - 20

SP - 656

EP - 667

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 6

ER -